Hostname: page-component-cd9895bd7-hc48f Total loading time: 0 Render date: 2024-12-23T03:44:36.285Z Has data issue: false hasContentIssue false
  • English
  • Français

How increasing the effect of rTMS in the treatment of auditory hallucinations in schizophrenia?

Published online by Cambridge University Press:  23 March 2020

S. Dollfus ,
C. Nathou  and
E. Olivier
S. Dollfus*
Affiliation:
CHU de Caen, Department of psychiatry, Caen, France
C. Nathou
Affiliation:
CHU Caen, Department of psychiatry, Caen, France
E. Olivier
Affiliation:
CHU de Caen, Department of neurophysiology, Caen, France
*
* Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Repetitive transcranial magnetic stimulation (rTMS) shows a high inter-subjects variability in the efficacy of treatment of auditory verbal hallucinations (AVH) in schizophrenia. The aim of this presentation is to demonstrate the involvement of several factors in the efficacy of rTMS such as the frequency of stimulation, the placebo effect and the brain morphology underlying the target of stimulation.

Methods

A meta-analysis was conducted to determine the effect sizes of placebo effect in 21 controlled studies on rTMS in the treatment of AVH in schizophrenia. MRI was also acquired in patients treated by rTMS to evaluate the scalp to cortex distances (SDCs) and the gray matter densities (GMDs) at the target of stimulation. Finally, we evaluated the efficacy of high (20 Hz) frequency stimulation in a controlled placebo study.

Results

Weak or no placebo effect in the control groups led to reveal a superiority of active rTMS over sham rTMS in the treatment of AVH. Clinical efficacy of rTMS was also correlated with the SCD or the GMD at the region of the target stimulation. Finally, we also demonstrated that more responders were observed after 2 weeks in the active group treated by 20 Hz than in the placebo group.

Conclusion

We clearly demonstrated that several factors such as high frequency, the placebo effect, anatomical cortical variations can impact on the efficacy of rTMS. These results fundamentally inform the design and the method of further controlled studies, particularly with respect to studies of rTMS in the treatment of AVH.

Disclosure of interest

The authors have not supplied their declaration of competing interest.

Type
S107
Information
European Psychiatry , Volume 33 , Issue S1: Abstracts of the 24th European Congress of Psychiatry , March 2016 , pp. S52
Copyright
Copyright © European Psychiatric Association 2016
Submit a response

Comments

No Comments have been published for this article.